To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research
To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

TOKYO, Nov 22, 2022 – (JCN Newswire via SEAPRWire.com) – Shimadzu Corporation (Shimadzu), Eisai Co., Ltd. (Eisai), Oita University, and Usuki City Medical Association hereby announce the commencement of a cohort study using Usuki City as a demonstration site. This joint study will attempt to develop Japan’s first diagnostic workflow for mild cognitive impairment (MCI)... » read more

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

SHANGHAI, CHINA, Oct 10, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, HKEx Stock Code: 2552.HK) today announces that the New Drug Application (NDA) of HuaTangNing (dorzagliatin tablets, HMS5552), a first-in-class glucokinase activator (GKA) developed by the Company has been approved by the National Medical Products Administration (NMPA) of China on October... » read more

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain

Singapore, Sep 7, 2021 – (ACN Newswire via SEAPRWire.com) – Local family cord blood bank Cryoviva Singapore (https://cryoviva.com.sg) is continuing with its rapid geographic growth plans with an entry into the Bahrain market. This latest new market entry closely follows Cryoviva establishing a footprint in Dubai to serve couples in the UAE that are on... » read more

Singapore cord blood bank Cryoviva establishes footprint in the UAE
Singapore cord blood bank Cryoviva establishes footprint in the UAE

Singapore, Jul 27, 2021 – (ACN Newswire via SEAPRWire.com) – Family cord blood bank Cryoviva Singapore is pleased to announce that it has made a successful foray into the UAE market in line with its strategic growth plans. After 7 years of serving young families in Singapore, the expansion into Dubai and the other Emirates... » read more

Stimulating blood vessel formation with magnets
Stimulating blood vessel formation with magnets

TSUKUBA, Japan, Jul 22, 2021 – (ACN Newswire via SEAPRWire.com) – Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. The findings, by researchers at the Tecnico Lisboa and NOVA School of Science and Technology in Portugal, could lead to... » read more

Temasek Foundation to provide every household in S’pore with one oximeter

SINGAPORE – Temasek Foundation will be giving one oximeter to every household in Singapore so that residents can monitor their blood oxygen levels regularly. This initiative comes as new and more infectious Covid-19 variants emerge. “The Covid-19 virus can cause blood oxygen levels to drop to dangerously low levels, even when you have no other symptoms,”... » read more

Olympics: ‘Game-changing’ drug tests to be trialled in Tokyo

MONTREAL (AFP) – The World Anti-Doping Agency (Wada) said on Friday (May 21) it will trial the use of dried blood spot testing at the Tokyo Olympics, an innovative new technique hailed as a potential “game-changer” in the fight against drug cheats. Speaking following a virtual meeting of the global anti-doping watchdog’s board and executive... » read more

Fewer blood donors in Singapore in 2020, but collection at 5-year high
Fewer blood donors in Singapore in 2020, but collection at 5-year high

SINGAPORE – Since he was seven, Mr Jack Goh, 33, has been visiting hospitals every three weeks to receive blood transfusions, and he has to do this for life. The private-hire driver has thalassaemia major, a blood disorder in which the body does not produce enough haemoglobin, a protein in red blood cells. According to... » read more

How the blood test works

The new blood test for early detection of gastric cancer takes around three hours to process in a clinical lab and patients can expect results to be delivered to their doctor in a week. The blood test detects the patterns of microRNA – a type of genetic material present in the blood sample. Most cancers,... » read more